The pharma industry just got some big news this week. International pharmaceutical company Sun Pharma Advanced Research Company Ltd. and Sun Pharmaceutical Industries Ltd, just announced a licensing arrangement for SPARC’s Elepsia XR. Elepsia XR is a novel investigational product designed as an extended release formulation of levetiracetam 1000 mg and 1500 mg. Levetiracetam is … Continue reading “Epilepsy Drug Agreement Sends SPARC Shares Flying”
